Wells Fargo
COYA icon

Wells Fargo’s Coya Therapeutics COYA Stock Holding History

Wells Fargo’s Portfolio COYA Stock Details COYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.92K Hold
500
– – ﹤0.01% 6312
2026
Q1 		$1.97K Buy
+500
New +$2.34K ﹤0.01% 6252
2024
Q2 		– Sell
-100
Closed -$992 – 7002
2024
Q1 		$992 Buy
100
+35
+54% +$274 ﹤0.01% 6153
2023
Q4 		$482 Buy
65
+4
+7% +$22 ﹤0.01% 6393
2023
Q3 		$234 Buy
61
+38
+165% +$151 ﹤0.01% 6547
2023
Q2 		$94 Buy
23
+1
+5% +$5 ﹤0.01% 6881
2023
Q1 		$87 Buy
+22
New +$96 ﹤0.01% 6964

Other funds holding COYA

DCM
DME Capital Management New York $3.91B AUM 36.1% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
PMG
Private Management Group Irvine, California $3.8B AUM 23.19% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return

Wells Fargo's COYA Position: Q2 2026 in Review

Wells Fargo held its Coya Therapeutics (COYA) position steady in Q2 2026 at 500 shares worth $2.92K. The position accounts for ﹤0.01% of the portfolio, ranked #6312.

Wells Fargo first reported a position in COYA in Q1 2023 and has held it in 7 quarters since. 54 funds tracked by Wall St. Rank hold COYA as of Q2 2026.

  • Wells Fargo held 500 shares of Coya Therapeutics worth $2.92K as of Q2 2026.
  • Wells Fargo left its Coya Therapeutics share count unchanged in Q2 2026.
  • Coya Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6312 holding.
  • Wells Fargo first reported a position in Coya Therapeutics in Q1 2023 and has held it in 7 quarters since.
  • 54 funds tracked by Wall St. Rank held Coya Therapeutics as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.